Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Not Yet RecruitingNCT07635511
What this trial is testing

Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies

Who this might be right for
Hematological MalignanciesPlatelet Transfusion Refractoriness (PTR)HLA Antibodies
The First Affiliated Hospital of Soochow University 42
Not applicableUnknownNCT03687463
What this trial is testing

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Who this might be right for
Hematopoietic System--Cancer
Capital Research Institute of Pediatrics 6
Testing effectiveness (Phase 2)UnknownNCT04582604
What this trial is testing

Ruxolitinib and Decitabine for High Risk Hematological Malignancies

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01025778
What this trial is testing

Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia
Lund University Hospital 7
Testing effectiveness (Phase 2)Study completedNCT01086735
What this trial is testing

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Assistance Publique - Hôpitaux de Paris 11
Early research (Phase 1)Study completedNCT01607892
What this trial is testing

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Who this might be right for
Hematological Malignancies
Karyopharm Therapeutics Inc 286
Not applicableStudy completedNCT03896880
What this trial is testing

Detection of Bloodstream Pathogens in Hematological Malignancies

Who this might be right for
Bloodstream Infection
Assiut University 139
Not applicableStudy completedNCT02353559
What this trial is testing

Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia

Who this might be right for
Acute Leukemia
University Health Network, Toronto 47
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Post-approval studies (Phase 4)Study completedNCT07811856
What this trial is testing

Effects of Metformin and Theory-Based Education in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome (PCOS) Women
Jerash Private University 900
Testing effectiveness (Phase 2)Ended earlyNCT04735575
What this trial is testing

A Ph1/2 Study of EMB-06 in Participants With Relapsed or Refractory Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Shanghai EpimAb Biotherapeutics Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Not applicableUnknownNCT02828462
What this trial is testing

Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics

Who this might be right for
Metastatic CancerHematological Malignancy
Gustave Roussy, Cancer Campus, Grand Paris 1,000
Testing effectiveness (Phase 2)Study completedNCT01084252
What this trial is testing

Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Who this might be right for
Hematological Malignancy
Sanofi 351
Post-approval studies (Phase 4)Study completedNCT03649334
What this trial is testing

Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy

Who this might be right for
Hematological Malignancy (Leukemia- Lymphoma)
Mansoura University 80
Not applicableStudy completedNCT05763563
What this trial is testing

Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy

Who this might be right for
LymphomaLeukemiaMyeloma
H. Lee Moffitt Cancer Center and Research Institute 20
Not applicableStudy completedNCT00876148
What this trial is testing

Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting

Who this might be right for
Hepatitis B VirusAllograftHematological Malignancies
Azienda Ospedaliera San Giovanni Battista
Early research (Phase 1)Active Not RecruitingNCT05347225
What this trial is testing

Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005)

Who this might be right for
Hematological Malignancies
Merck Sharp & Dohme LLC 12
Very early researchUnknownNCT06393335
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
The Children's Hospital of Zhejiang University School of Medicine 36
Next Page